Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

8.7K
8.7K
Ligand Binding Sites02:40

Ligand Binding Sites

14.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.9K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K
Drug Discovery: Overview01:26

Drug Discovery: Overview

11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

4.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel 1<i>H</i>-1,2,3-Triazole Derivatives of Praziquantel with TRPM<sub>PZQ</sub> Modulatory Activity and Antiparasitic Effects on Larvae, Juvenile, and Adult Worms of <i>Schistosoma mansoni</i>.

ACS infectious diseases·2025
Same author

RND/HAE-1 members in the Pseudomonadota phylum: exploring multidrug resistance.

Biophysical reviews·2025
Same author

Gene Expression and Prognostic Value of NADPH Oxidase Enzymes in Breast Cancer.

International journal of molecular sciences·2024
Same author

Discovery of new Schistosoma mansoni aspartyl protease inhibitors by structure-based virtual screening.

Memorias do Instituto Oswaldo Cruz·2023
Same author

AI-Driven Discovery of SARS-CoV-2 Main Protease Fragment-like Inhibitors with Antiviral Activity <i>In Vitro</i>.

Journal of chemical information and modeling·2023
Same author

Hybrids of Imatinib with Quinoline: Synthesis, Antimyeloproliferative Activity Evaluation, and Molecular Docking.

Pharmaceuticals (Basel, Switzerland)·2022

Related Experiment Video

Updated: Jan 19, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.1K

Key Topics in Molecular Docking for Drug Design.

Pedro H M Torres1, Ana C R Sodero2, Paula Jofily3

  • 1Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK. monteirotorres@gmail.com.

International Journal of Molecular Sciences
|September 22, 2019
PubMed
Summary
This summary is machine-generated.

Molecular docking, a key drug discovery technique, faces challenges in identifying true ligands and conformations. Recent advances in benchmarking, consensus methods, fragment-based approaches, and machine learning are improving accuracy.

Keywords:
benchmarking setscomputer-aided drug designconsensus methodsfragment-basedmachine learningstructure-based drug design

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.7K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

956

Related Experiment Videos

Last Updated: Jan 19, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.1K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.7K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

956

Area of Science:

  • Computational Chemistry
  • Structural Biology
  • Drug Discovery

Background:

  • Molecular docking is a widely used computational method for drug discovery.
  • Despite its widespread use, challenges remain in accurately identifying ligands and their binding conformations.
  • Continuous development of new approaches is crucial for advancing the field.

Purpose of the Study:

  • To provide an overview of molecular docking methodologies.
  • To summarize recent advancements in key areas of molecular docking.
  • To highlight the impact of new techniques on the accuracy and potential of molecular docking.

Main Methods:

  • Review of existing literature on molecular docking.
  • Analysis of recent developments in benchmarking datasets.
  • Examination of advances in consensus methods, fragment-based approaches, and machine learning algorithms.

Main Results:

  • Recent developments in benchmarking sets offer improved evaluation of docking protocols.
  • Consensus methods and fragment-based approaches show promise in enhancing prediction accuracy.
  • Machine learning algorithms are increasingly integrated into molecular docking workflows.

Conclusions:

  • Ongoing advancements are incrementally improving the accuracy of molecular docking.
  • The integration of new methods, coupled with increased computing power, is expected to unlock the full potential of molecular docking.
  • Molecular docking remains a vital and evolving tool in computational drug discovery.